Tạo 2 slide nói về nghiên cứu Navotrial 03 (ung thư phổi tế bào vảy) - slide 1: thiết kế nghiên cứu - slide 2: 2 biểu đồ gồm 1 biểu đồ về PFS và 1 biểu đồ về OS

Created using ChatSlide

This presentation outlines the NAVoTrial 03 study, an international, multicenter, open-label randomized phase II trial in patients with previously untreated advanced squamous non-small cell lung cancer. It reviews the prospective study design and compares progression-free and overall survival between treatment arms, including Kaplan–Meier PFS findings. PFS was similar between arms (4.2 versus 4.3 months), while median overall survival favored Arm A (10.2 versus 8.4 months).